MD Douglas Reed Net Worth & Insider Trades

MD Douglas Reed G1 Therapeutics, Inc

As of June 1, 2018

What is MD Douglas Reed's Net Worth?

The current estimated net worth of G1 Therapeutics, Inc's MD Douglas Reed is estimated to be about $69.76M . MD Douglas Reed owns about 3,237,711 units of G1 Therapeutics, Inc common stock. In the last year at G1 Therapeutics, Inc, MD Douglas Reed has sold an estimated value of $40.32M worth.

What is MD Douglas Reed's Past Insider Trading?

MD Douglas Reed's largest purchase order was 4,173,729 units , worth over $2M on May 24, 2017. MD Douglas Reed's largest sale order was 800,000 units , worth over $38.4M on June 1, 2018. In total, MD Douglas Reed has made about 4 transactions over a year of their time at G1 Therapeutics, Inc. MD Douglas Reed usually trades in May, with the busiest year in 2017 and 2018.

Clay Thorp, Hatteras Venture Advisors IV SBIC LLC, Hatteras Venture Partners IV SBIC LP, ALEXANDER ROBERT INGRAM, John Crumpler, KENNETH LEE JR, MD Douglas Reed

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is MD Douglas Reed's' Mailing Address?

  • Mailing address is C/o Vector Fund Management 1751 Lake Cook Road, Suite 350 Deerfield IL 60015 IL

G1 Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John E. Bailey, Jr. 2020 - $542,109 - $215,948 $758,057
Mark A. Velleca, M.D., Ph.D. 2020 $608,308 $3,069,704 $305,000 $8,550 $3,991,562
Mark A. Velleca, M.D., Ph.D. 2019 $589,700 $3,105,237 $280,108 $8,400 $3,983,445
Mark A. Velleca, M.D., Ph.D. 2018 $515,000 $1,044,529 $321,875 $33,250 $1,914,654
Jennifer K. Moses 2020 $398,583 $1,116,239 $141,050 $8,550 $1,664,422
Jennifer K. Moses 2019 $315,598 $972,601 $117,600 $8,400 $1,414,199
Mark Avagliano 2020 $431,417 $837,165 $151,200 $18,445 $1,438,227
Mark Avagliano 2019 $181,913 $5,100,560 $142,800 $53,117 $5,478,390
Rajesh K. Malik, M.D. 2020 $424,000 $836,733 $148,750 $8,550 $1,418,033
Rajesh K. Malik, M.D. 2019 $413,000 $828,195 $138,768 $8,400 $1,388,363
Rajesh K. Malik, M.D. 2018 $400,000 $696,968 $169,400 $8,250 $1,274,618
Soma Gupta 2020 $320,360 $2,212,758 $114,662 $100,000 $2,747,780
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1560241/000119312521136977/d122680ddef14a.htm

What are G1 Therapeutics, Inc's Past Insider Trades?

G1 Therapeutics, Inc's most recent insider trade came on January 5, 2023 by Jennifer Moses who sold 2,368 units worth $13.08K . In the last 6 years, insiders at G1 Therapeutics, Inc have sold an estimated value of $69.69M and bought an estimated value of $25.76M worth of shares. Insider trading is most common in January, with the busiest year in 2018. The most active traders at the company are Rajesh Malik, Chief Medical Officer,  Mark Velleca,  and Jennifer Moses, CFO .

G1 Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1